Humoral innate immunity and acute-phase proteins
Humoral Innate Immunity and Acute-Phase Proteins | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
Immune responses to human fungal pathogens and therapeutic prospects
Pathogenic fungi have emerged as significant causes of infectious morbidity and death in
patients with acquired immunodeficiency conditions such as HIV/AIDS and following receipt …
patients with acquired immunodeficiency conditions such as HIV/AIDS and following receipt …
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of
commonly used antifungal agents is unprecedented. The azoles, for example, are used not …
commonly used antifungal agents is unprecedented. The azoles, for example, are used not …
Aspergillus fumigatus morphology and dynamic host interactions
Aspergillus fumigatus is an environmental filamentous fungus that can cause life-threatening
disease in immunocompromised individuals. The interactions between A. fumigatus and the …
disease in immunocompromised individuals. The interactions between A. fumigatus and the …
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
Abstract Long pentraxin 3 (PTX3) is an essential component of humoral innate immunity,
involved in resistance to selected pathogens and in the regulation of inflammation,–. The …
involved in resistance to selected pathogens and in the regulation of inflammation,–. The …
Breakthrough invasive fungal infections: Who is at risk?
The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has
changed over the last few decades, partially due to the increased use of antifungal agents to …
changed over the last few decades, partially due to the increased use of antifungal agents to …
[HTML][HTML] PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer
PTX3 is an essential component of the humoral arm of innate immunity, playing a
nonredundant role in resistance against selected microbes and in the regulation of …
nonredundant role in resistance against selected microbes and in the regulation of …
Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
Y Schmiedel, S Zimmerli - Swiss medical weekly, 2016 - boris.unibe.ch
Every year, Candida, Aspergillus, Cryptococcus and Pneumocystis infect an estimated two
million individuals worldwide. Most are immunocompromised or critically ill. Candida is the …
million individuals worldwide. Most are immunocompromised or critically ill. Candida is the …
Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of …
Breakthrough invasive fungal infections (IFI s) have emerged as a significant problem in
patients receiving systemic antifungals; however, consensus criteria for defining …
patients receiving systemic antifungals; however, consensus criteria for defining …